GCLC and glioblastoma: We further demonstrate that auranofin, in combination with L-buthionine-sulfoximine (L-BSO), known to deplete GSH through inhibition of GCLC, has synergistic lethality in GBM cells irrespective of EGFRwt and EGFRvIII overexpression in vitro.